NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
SoundHound AI
SOUN
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
XCUR Exicure
- 9.4500
- +1.8400+24.18%
Close Feb 28 16:00 ET
- 9.4500
- 0.00000.00%
Post 20:01 ET
28.72MMarket Cap-4.68P/E (TTM)
9.4881High7.5400Low32.78KVolume7.5400Open7.6100Pre Close287.07KTurnover2.50%Turnover RatioLossP/E (Static)3.04MShares36.000052wk High18.60P/B12.39MFloat Cap1.440052wk Low--Dividend TTM1.31MShs Float576.0000Historical High--Div YieldTTM25.60%Amplitude1.4400Historical Low8.7570Avg Price1Lot Size
About Exicure Company
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Company Profile
SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Andy Yoo
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com
Company Executives
- Name
- Position
- Salary
- Paul Kang
- Director, Chief Executive Officer and President
- 16.94K
- Andy Yoo
- Director, Chief Executive Officer and President
- --
- Jiyoung Hwang
- Director and Chief Strategic Officer
- 16.97K
- Seung Ik Baik
- Director, Chief Financial Officer and Secretary
- --
- Joshua Miller
- Chief Accounting Officer
- --
- Ho Jung John
- Director
- --
- Chang Keun Choi
- Director
- --
- Sangwook Song
- Director
- --
- Minwoo Kang
- Director
- --
- Dongho Lee
- Independent Director
- 7.22K